{"transactions":[{"id":2255699,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:10:53.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":80000,"derivative":{"exercise_price":0.3377,"expiration_date":"2032-05-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-22-032175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919122032175/doc4.xml","form_type":"4"}},{"id":2674438,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T22:56:43.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2020 Equity Incentive Plan and based on the closing price of $3.16 per share, on the day immediately preceding the date of the Company's 2021 annual meeting."}],"balance_after":55223,"source":{"system":"sec-edgar","filing":"0001209191-21-039634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121039634/doc4.xml","form_type":"4"}},{"id":2864248,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T22:13:53.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":17022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the\nCompany's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $2.35 per share, on the day immediately\npreceding the date of the Company's 2019 annual meeting."}],"balance_after":42565,"source":{"system":"sec-edgar","filing":"0001209191-21-010231","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000120919121010231/doc5.xml","form_type":"5"}},{"id":3530298,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T20:01:50.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of the annual board retainer for each non-employee director payable in immediately vested, common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $5.51 per share, on the day immediately preceding the date of the Company's 2019 annual meeting."}],"balance_after":25543,"source":{"system":"sec-edgar","filing":"0001144204-19-025605","document":"tv521407_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420419025605/tv521407_4.xml","form_type":"4"}},{"id":3789193,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-17T12:48:12.000Z","date":"2018-10-16","kind":"grant","acquired":true,"shares":5168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of the annual board retainer for each non-employee director payable in immediately vested, common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $7.74 per share, on the day immediately preceding the date of the Company's 2018 annual meeting."}],"balance_after":18283,"source":{"system":"sec-edgar","filing":"0001144204-18-054103","document":"tv504933_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418054103/tv504933_4.xml","form_type":"4"}},{"id":4221884,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":126886,"kind":"person","name":"Laskow-Pooley David","position":1,"cik":"0001638533","reported_name":"Laskow-Pooley David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-30T20:03:25.000Z","date":"2017-08-29","kind":"grant","acquired":true,"shares":13115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of the annual retainer for each non-employee director payable in immediately vested restricted, common stock under the Company's 2014 Omnibus Stock Ownership Plan and based on the closing price of $3.05 per share, on the day immediately preceding the date of the Company's 2017 annual meeting."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0001144204-17-045905","document":"v474357_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417045905/v474357_4.xml","form_type":"4"}}]}